Chinese Journal of Pharmacovigilance ›› 2011, Vol. 8 ›› Issue (4): 225-228.

Previous Articles     Next Articles

Discussion on the Situation of Drug Post-marketed Reassessment in China

LI Man1, WANG Zhong2, ZHANG Xiang-lin3   

  1. 1. School of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang, 110016, China;
    2. China Academy of Chinese Medical Sciences, Beijing 100700, China;
    3. Chinese Pharmacopoeia Commission, Beijing 100061, China
  • Received:2010-12-17 Revised:2015-08-27 Online:2011-04-10 Published:2015-08-27

PDF (PC)

499

Abstract: On the basis of expounding the situation of drug post-marketed reassessment, the problems of reassessment status have been analyzed. And relevant suggestions have been provided for improving drug post-marketed reassessment.

Key words: drug, post-marketed reassessment, adverse drug reaction(ADR), evaluation method

CLC Number: